Roflumilast for Hard-to-Treat Skin Folds and Genital Psoriasis
Treatments studied
Part of Skin clinical trials.
This trial tests whether a medication called roflumilast can help psoriasis in skin folds (like armpits or groin) that hasn't improved with creams or ointments. Researchers want to see if this pill or oral treatment works better than standard care for these sensitive areas.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have psoriasis in skin folds and/or genital area that didn't clear up after 4–6 weeks of regular topical cream treatment
- You have not taken oral psoriasis medications in the last 3 months
- You have not used topical psoriasis treatments for at least 2 weeks before starting the study
- You do not have serious heart, lung, kidney, liver, or gut disease
- You are not pregnant, breastfeeding, or allergic to roflumilast or methotrexate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an oral medicine called roflumilast for adults with moderate to severe plaque psoriasis. It aims to see if the drug is safe and effective when taken by mouth, and you can join if you have not used other systemic treatments recently.
This trial tests a cream called roflumilast for people with plaque psoriasis on the body and nail psoriasis. It aims to see if the cream safely improves both skin and nails.
This study tests whether adding roflumilast, a new medication, to your current rheumatoid arthritis treatment can help reduce joint inflammation and improve your symptoms. You would take it alongside methotrexate, a common RA medication you may already be using.
This study tests an oral medicine called roflumilast to see if it helps treat moderate to severe eczema in people aged 12 and up who haven't used other systemic treatments recently. It's a pilot study to check both safety and how well it works.
This study tests whether a new foam treatment (roflumilast) can safely reduce skin rashes, itching, and other skin problems caused by checkpoint inhibitor cancer drugs. If you've developed these skin side effects from immunotherapy, this trial may help ease your symptoms.
This trial tests a medicated foam called roflumilast to treat seborrheic dermatitis, a skin condition that causes redness, itching, and flaking. It may help people who have moderate to severe symptoms on their face, scalp, or body.
Hear when a new Flexural Psoriasis (Also Known as Inverse or Intertriginous Psoriasis) and Genital Psoriasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.